Spyre Therapeutics SYRE 深 沪
等待开盘 10-09 09:30:00 美东时间
79.90
-0.950
-1.18%
华盛通- 最 高80.91
- 今 开79.58
- 成交量 232.67万股
- 最 低 77.05
- 昨 收 80.85
- 总市值 70.45亿
- 52周最高 110.175
- 市盈率 静 --
- 换手率 2.64%
- 52周最低 21.145
- 委 比 99.98%
- 总股本 8817.38万
- 历史最高 318.75
- 量 比 1.11
- 振 幅 4.77%
- 历史最低 2.66
- 每 手 1
- 风险率 28.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Spyre Therapeutics announces proposed public offering of common stock
Spyre Therapeutics (SYRE) said on Monday it commenced an underwritten public offering of its common stock, with the underwriters granted a 30-day option to purchase up to an additional 15% of the shar...
10-06 04:06
Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics, a clinical-stage biotechnology company, announced that its Compensation Committee approved the grant of stock options and restricted stock units (RSUs) to two non-executive employees under the 2018 Equity Inducement Plan. The options, totaling 21,424 shares, and RSUs, totaling 6,604 shares, were granted on October 1, 2026, with an exercise price of $89.93 per share. The stock options vest 25% on the first anniversary of the em...
10-02 20:05
美股大行评级 | 潜在涨幅1654.39%！Ascendiant Capital上调NRX Pharmaceuticals(NRXP)目标价至50美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从49美元升至50美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从24美元升至25美元
10-02 08:33
Hewlett Packard Enterprise, Capital Bancorp, FormFactor And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Wednesday. Shares of Hewlett Packard Enterprise Co (NYSE:HPE) rose during Wednesday’s session after the company announced it raised its FY27 networking segment revenue growth guidance. Also, the company announced an order ...
09-30 21:55
美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
美股大行评级 | 多家大行齐上调Robinhood目标价！最高看至150美元；安进股价大跌后评级遭下调
今日重点评级关注：Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.3美元升至8.45美元；摩根大通：维持Vera Therapeutics"超配"评级，目标价从76美元升至83美元
09-09 15:36
BTIG Reiterates Buy on Spyre Therapeutics, Maintains $121 Price Target
BTIG analyst Julian Harrison reiterates Spyre Therapeutics (NASDAQ:SYRE) with a Buy and maintains $121 price target.
09-08 23:22
Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations
Spyre Therapeutics announced positive 12-week induction data from Part A of the Phase 2 SKYLINE trial for SPY003, a potential best-in-class anti-IL-23 for moderately-to-severely active ulcerative colitis (UC). SPY003 met its primary endpoint with a statistically significant 10.0-point reduction in Robart’s Histopathology Index (RHI) score (p<0.0001) and achieved meaningful clinical remission and endoscopic improvement. The safety profile was cons...
09-08 12:00
Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics granted stock options for 2,106 shares and 745 RSUs to a non-executive employee under its 2018 Equity Inducement Plan on September 1, 2026. The stock options have a 10-year term with an exercise price of $88.50, vesting 25% on the first anniversary of the employee's start date and monthly thereafter. The RSUs vest quarterly starting from the first anniversary. The company aims to develop next-generation immunology therapies.
09-04 20:01
美股大行评级 | 潜在涨幅1849.95%！Ascendiant Capital上调IGC Pharma目标价至6美元，维持"买入"评级；迪克体育、财捷遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.5美元升至6美元；Ascendiant Capital：维持Quantum Computing"买入"评级，目标价从30美元升至32美元
08-27 08:37
